Hopman Mark — SEC Form 4 filings
SEC reporting owner CIK 2048497. 19 Form 4 filings on record with FilingPulse; latest filed 2026-09-18.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2025-01-31 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 15 filings — 156,814 shares, $2,941,642 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 36,870 shares @ $18.46 ($680,723) in Beta Bionics, Inc., filed 2026-09-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | 19 | — | 19 legs · 156,814 sh · $2,941,642 | 19 |
Form 4 filings — Hopman Mark
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4/A | Beta Bionics, Inc. (BBNX) | Sale (S): 35,994 @ $18.46 | EDGAR |
| 2026-09-17 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 30,779 @ $20.13 | EDGAR |
| 2026-09-15 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 775 @ $15.52 | EDGAR |
| 2026-09-10 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 36,870 @ $18.46 | EDGAR |
| 2026-09-03 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 5,327 @ $19.11 | EDGAR |
| 2026-06-25 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 1,258 @ $15.01 | EDGAR |
| 2026-06-05 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 275 @ $12.31 | EDGAR |
| 2026-06-03 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 5,329 @ $12.61 | EDGAR |
| 2026-03-16 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 856 @ $29.34 · Sale (S): 2,061 @ $30.66 | EDGAR |
| 2026-03-13 | 4/A | Beta Bionics, Inc. (BBNX) | Grant/award (A): 91,520 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 353 @ $11.57 | EDGAR |
| 2026-03-03 | 4 | Beta Bionics, Inc. (BBNX) | Grant/award (A): 109,105 @ $0 · Sale (S): 834 @ $12.36 · Grant/award (A): 58,749 (derivative) @ $0 | EDGAR |
| 2025-09-08 | 4 | Beta Bionics, Inc. (BBNX) | Option exercise (M): 656 @ $5.10 · Option exercise (M): 4,093 @ $5.10 · Sale (S): 6,818 @ $19.97 · Option exercise (M): 11,411 @ $5.10 · Sale (S): 11,411 @ $20.56 · Option exercise (M): 656 (derivative) @ $0 · +2 more | EDGAR |
| 2025-09-04 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 848 @ $18.86 | EDGAR |
| 2025-08-20 | 4 | Beta Bionics, Inc. (BBNX) | Option exercise (M): 16,158 @ $5.10 · Sale (S): 16,158 @ $16.61 · Option exercise (M): 16,158 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 238 @ $17.03 · Sale (S): 551 @ $18.15 · Sale (S): 79 @ $18.69 | EDGAR |
| 2025-03-03 | 4 | Beta Bionics, Inc. (BBNX) | Grant/award (A): 35,000 @ $0 · Grant/award (A): 52,000 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | Beta Bionics, Inc. (BBNX) | Grant/award (A): 83,242 (derivative) @ $0 · Grant/award (A): 37,229 (derivative) @ $0 · Grant/award (A): 17,765 (derivative) @ $0 · Grant/award (A): 39,424 (derivative) @ $0 · Grant/award (A): 47,775 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | Beta Bionics, Inc. (BBNX) | Grant/award (A): 47,775 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2048497 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →